JANX Q1 2021 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$380,000

Gross Profit

-$2M-406.6% margin

Operating Income

-$2M-601.1% margin

Net Income

-$2M-601.1% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$5M

Stock-Based Comp.

$123,000

Balance Sheet

Total Assets

$72M

Total Liabilities

$89M

Stockholders' Equity

-$17M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$380,000	$0	—
Gross Profit	-$2M	$0	—
Operating Income	-$2M	-$826,000	-176.5%
Net Income	-$2M	-$1M	-61.6%